Drug Industry’s Chief Lobbying Group’s Revenue Surpassed $609 Million in 2021

  • 📰 truthout
  • ⏱ Reading Time:
  • 31 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 68%

España Noticias Noticias

España Últimas Noticias,España Titulares

In 2021, the drug industry’s chief lobbying group surpassed $609 million in revenues and spent more than $205 million on lobbying. Via Sludge

PhRMA represents 33 American and multinational drug companies, including the largest ones like Pfizer, Johnson & Johnson, AbbVie, and Merck. Its chief executive office since 2015, Stephen Ubl, was paid more than $6.1 million in 2021, according to the tax filing.

One of PhRMA’s chief aims in 2021 was to kill a proposal that congressional Democrats had been pushing in recent years to allow Medicare to negotiate with drug companies for lower prices and require drug companies to make the lower negotiated prices available to all buyers, including private insurance companies. That proposal sat in Congress as H.R.3, which is by far thein PhRMA’s 2021 lobbying disclosures.

Another large contribution made by PhRMA in 2021 was a $1.7 million donation to Center Forward, which is a nonprofit tied to the conservative Blue Dog Caucus of Democrats that has

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

 /  🏆 69. in ES
 

Gracias por tu comentario. Tu comentario será publicado después de ser revisado.

PortCityPisces Sludge

España Últimas Noticias, España Titulares